Hims & Hers Health, INC Form 4 insider transactions

Director Christiane Pendarvis of Hims & Hers Health, Inc. sold 4,000 shares of Class A Common Stock at a price of $12.33 on May 13, 2024.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,503 shares of Class A Common Stock at a price of $12.33 on May 13, 2024.

Patrick Harrison Carroll, Chief Medical Officer and Director of Hims & Hers Health, Inc., sold 10,000 shares of Class A Common Stock for $13 per share on May 9, 2024.

Director Anja Manuel reports acquisition of 30,120 Restricted Stock Units in Hims & Hers Health, Inc. with vesting over a three-year period.

Director Christopher D. Payne acquired 30,120 restricted stock units in Hims & Hers Health, Inc., subject to a three-year vesting schedule.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares on May 1, 2024, according to a Form 4 filing with the SEC.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares of Class A Common Stock between May 1 and May 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,503 shares of Class A Common Stock at a price of $12.56 per share on April 29, 2024, under a pre-arranged 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,503 shares of Class A Common Stock at $13.95 per share on April 15, 2024, under a pre-arranged 10b5-1 trading plan.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, executed stock option exercises and sales of Class A Common Stock between April 4th and April 8th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on April 4, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,503 shares of Class A Common Stock at a price of $15.65 per share on April 1, 2024, under a pre-arranged 10b5-1 trading plan.

Andrew Dudum, CEO of Hims & Hers Health, sold 50,361 shares of Class A Common Stock on March 20, 2024, at an average price of $16.3431.

Hims & Hers Health CFO Oluyemi Okupe sold 9,912 shares of Class A Common Stock on March 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Irene Becklund, PAO of Hims & Hers Health, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units, including transactions related to tax obligations and a pre-arranged trading plan.

Director Lynne Chou O'Keefe reports converting Restricted Stock Units (RSUs) into Class A Common Stock and selling shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Director Christiane Pendarvis of Hims & Hers Health, Inc. reports the vesting of 15,210 Restricted Stock Units (RSUs) on March 15, 2024, convertible to Class A Common Stock.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, reports the vesting and disposal of restricted stock units (RSUs) to cover tax obligations.

Oluyemi Okupe, CFO of Hims & Hers Health, reports the vesting and disposal of restricted stock units to cover tax obligations.

Director David B. Wells reports the acquisition of 10,044 shares of Class A Common Stock and the disposition of 10,044 Restricted Stock Units of Hims & Hers Health, Inc.

Director Ambar Bhattacharyya reports the vesting of restricted stock units (RSUs) into Class A Common Stock of Hims & Hers Health, Inc.

Director Alex Bard reports acquisition and disposal of Hims & Hers Health, Inc. Class A Common Stock and Restricted Stock Units.

Chief Medical Officer Patrick Harrison Carroll of Hims & Hers Health, Inc. reports the vesting and disposal of restricted stock units to cover tax obligations.

Andrew Dudum, CEO of Hims & Hers Health, reports the vesting and settlement of restricted stock units and related tax withholding.

Michael Chi, Chief Marketing Officer of Hims & Hers Health, Inc., reported the vesting and subsequent sale of shares to cover tax obligations related to restricted stock units.

Director Andrea Perez Garcia reports vesting of restricted stock units in Hims & Hers Health, Inc.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports the vesting and disposal of restricted stock units (RSUs) to cover tax obligations.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., executed stock option exercises and sales of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Chief Operating Officer of Hims & Hers Health, Melissa Baird, reports exercising stock options and selling Class A Common Stock between March 5th and March 7th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Irene Becklund, PAO of Hims & Hers Health, sold 2,747 shares of Class A Common Stock and was granted 69,518 Restricted Stock Units (RSUs).